126 related articles for article (PubMed ID: 38247428)
1. Prevalence of primary chronic lymphocytic leukemia in the United States: a cross-sectional study using the
Fu S; Alhaj Z; Huynh D
Leuk Lymphoma; 2024 Apr; 65(4):541-542. PubMed ID: 38247428
[No Abstract] [Full Text] [Related]
2. Highlights in chronic lymphocytic leukemia from the 2020 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2020 Sep; 18 Suppl 13(9):1-20. PubMed ID: 33843884
[No Abstract] [Full Text] [Related]
3. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
[TBL] [Abstract][Full Text] [Related]
4. Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
Meacham PJ; Williams AM; Strawderman M; Baran AM; Archibald WJ; Wallace DS; Tschernia NP; Burack WR; Barr PM; Zent CS
Leuk Lymphoma; 2020 Jul; 61(7):1636-1644. PubMed ID: 32175786
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
6. High prevalence and incidence of cardiovascular disease in chronic lymphocytic leukaemia: a nationwide population-based study.
Larsson K; Mattsson M; Ebrahim F; Glimelius I; Höglund M
Br J Haematol; 2020 Aug; 190(4):e245-e248. PubMed ID: 32515008
[No Abstract] [Full Text] [Related]
7. Epidemiology of chronic lymphocytic leukaemia in an Irish subpopulation with total case ascertainment: an additional tool for health economic planning.
Waldron C; O'Brien D; Brophy S; Perera K; Crotty GM; Dunlea E; Walsh A; Connolly M; Clifford R; O'Leary H; Khan A; Lee G; Atkinson E; Le G; Gillett A; Bacon CL; McElligott AM; Quinn F; Vandenberghe E
Br J Haematol; 2022 Mar; 196(5):e47-e49. PubMed ID: 34783371
[No Abstract] [Full Text] [Related]
8. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
Alrawashdh N; Sweasy J; Erstad B; McBride A; Persky DO; Abraham I
Ann Hematol; 2021 Oct; 100(10):2501-2512. PubMed ID: 34279676
[TBL] [Abstract][Full Text] [Related]
9. Incidence rates of chronic lymphocytic leukemia in US states are associated with residential radon levels.
Schwartz GG; Klug MG
Future Oncol; 2016 Jan; 12(2):165-74. PubMed ID: 26515766
[TBL] [Abstract][Full Text] [Related]
10. An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis characterizes a recent database of chronic lymphocytic leukemia Rai stage 0.
Molica S; Gentile M; Mauro FR; Brugiatelli M; Federico M; Sperduti I; Neri A; Ferrarini M; Foà R; Morabito F
Acta Haematol; 2012; 127(3):149-51. PubMed ID: 22262125
[No Abstract] [Full Text] [Related]
11. Chronic lymphocytic leukemia in the elderly population.
Rai KR
Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
[TBL] [Abstract][Full Text] [Related]
12. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009.
Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP;
Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, distribution and predictive value of XPO1 mutation in a real-life chronic lymphocytic leukaemia cohort.
Tueur G; Lazarian G; Eclache V; Fleury C; Letestu R; Lévy V; Lefebvre V; Collon JF; Zini JM; Thieblemont C; Soussi T; Cymbalista F; Baran-Marszak F
Br J Haematol; 2020 Nov; 191(3):e90-e94. PubMed ID: 32790071
[No Abstract] [Full Text] [Related]
15. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
[TBL] [Abstract][Full Text] [Related]
16. Chronic lymphocytic leukemia.
Munir T
Hematology; 2015 May; 20(4):245-6. PubMed ID: 25906256
[No Abstract] [Full Text] [Related]
17. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
18. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
19. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.
Kabadi SM; Goyal RK; Nagar SP; Kaye JA; Davis KL
Cancer Med; 2019 Jul; 8(8):3803-3810. PubMed ID: 31144473
[TBL] [Abstract][Full Text] [Related]
20. Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States.
Saba L; Landau KS; Liang H; Fu CL; Chaulagain CP
Leukemia; 2024 Feb; 38(2):435-437. PubMed ID: 38049508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
